{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"The Psychedelic News Feed","title":"Oregon Backtracks on Fee Hike, California Funds Psychedelic Research, DEA Moves to Schedule 5 Tryptamines","html":"","width":"100%","height":180,"duration":1302,"description":"In this episode of The Psychedelic News Feed podcast, Psychedelic Alpha’s editor Josh Hardman runs through another busy two-week period in the field, including:\nOregon Health Authority’s decision to shelve its proposed doubling of fees levied on state-regulated psilocybin entities (ft. Taylor West, Exec. Director, Healing Advocacy)\nCalifornia carves out $4.7M for psychedelic research\nThe DEA again moves to schedule 5 tryptamines\nThe PATH Caucus publishes its RFI white paper\nStanford and UCSF researchers call for “more aggressive” blinding in psychedelic trials (ft. Joshua Woolley, UCSF)\n\nRead more:\nPsychedelic Bulletin 232: Oregon Backpedals Psilocybin Fee Hike; DEA Again Moves to Schedule 5 Tryptamines\n\nThe Psychedelic News Feed is published by Psychedelic Alpha and airs every two weeks.\n\nThis episode of The Psychedelic News Feed is supported by UBC. As psychedelic therapies move toward potential approvals, UBC helps sponsors navigate the evidence generation, pharmacovigilance, and comprehensive risk management strategies that support a path forward grounded in patient safety. Learn more at ubc.com.\n\nSend us your questions and comments at pod@psychedelicalpha.com \n\nRead more and join our newsletter at https://psychedelicalpha.com\n\nFollow us on Instagram @psychedelicalpha, X @Psyched_Alpha, and LinkedIn.\n\nSubscribe to Pα+ for premium insights: https://psychedelicalpha.com/join/ ","thumbnail_url":"https://img.transistorcdn.com/JloIlpLTBLPjk3I75jU_cRq8srB2BvAcUvjRPrSEM2M/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS83MDc4/NWQ1YzQ4ODk0YjVm/NzE0OWNlOTkyOWI5/MTU3OC5wbmc.webp","thumbnail_width":300,"thumbnail_height":300}